This document aims to assess the available preclinical and clinical information relating to dependency and withdrawal reactions to selective serotonin reuptake inhibitors (SSRIs). It proposes a harmonised wording relating to withdrawal reactions of SSRIs to be included in the summary of product characteristics.

Keywords: Selective serotonin uptake inhibitor (SSRIs), dependency, withdrawal reactions, pre-clinical, clinical

Current version

Share this page